The Traceability Gap: Managing Risk Across Suppliers Beyond Tier 1
click here to discover importer exporter profiles & logistic partners
Shipments
Markets
Products/HS Code
Imports and Exports Data of
we pharma ltd
unit 6.07 the light box 111 power road london, england, united kingdom
we pharma ltd is based out of united kingdom with 75 import shipments and 133 export shipments recorded in global import export data.
.
Trade Trends of we pharma ltd
from Jan 2022 to Sept 2025Shipments Imported: 75
As Buyer Trade Value (USD): $0
Shipments Exported: 133
As Supplier Trade Value (USD): $0
Import and Export shipments of "we pharma ltd"
| Consignee Name | HS Code | Shipment Date |
|---|---|---|
| 902519 | Jan 29, 2026 | |
we pharma ltd | 902519 | Jan 29, 2026 |
we pharma ltd | 902519 | Jan 29, 2026 |
we pharma ltd | 902519 | Jan 29, 2026 |
we pharma ltd | 902519 | Jan 29, 2026 |
Trademo turns 3B+ shipment records and 15M+ company profiles into actionable data for trade prospecting. Subscribe to Trademo Intel to grow the pipeline.
Solutions Built for Every Stage of Global Trade
Markets in which we pharma ltd trades
Products/HS Codes traded by we pharma ltd
Top HS Codes Imported by "we pharma ltd"
USD 0 | 57.33%
Pharmaceutical products Medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale. - Other
Pharmaceutical products Medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale. - Other
USD 0 | 8.00%
Pharmaceutical products Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products; cell cultures, whether or not modified. -- Immunological products, put up in measured doses or in forms or packings for retail sale
Pharmaceutical products Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products; cell cultures, whether or not modified. -- Immunological products, put up in measured doses or in forms or packings for retail sale
USD 0 | 4.00%
Organic chemicals Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds. - Compounds containing an unfused thiazole ring (whether or not hydrogenated) in the structure
Organic chemicals Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds. - Compounds containing an unfused thiazole ring (whether or not hydrogenated) in the structure
USD 0 | 1.33%
Pharmaceutical products Medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of two or more constituents which have been mixed together for therapeutic or prophylactic uses, not put up in measured doses or in forms or packings for retail sale. -- Other
Pharmaceutical products Medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of two or more constituents which have been mixed together for therapeutic or prophylactic uses, not put up in measured doses or in forms or packings for retail sale. -- Other
USD 0 | 1.33%
Pharmaceutical products Medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of two or more constituents which have been mixed together for therapeutic or prophylactic uses, not put up in measured doses or in forms or packings for retail sale. - Other
Pharmaceutical products Medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of two or more constituents which have been mixed together for therapeutic or prophylactic uses, not put up in measured doses or in forms or packings for retail sale. - Other
Top HS Codes Exported by "we pharma ltd"
USD 0 | 31.58%
Pharmaceutical products Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products; cell cultures, whether or not modified. -- Immunological products, put up in measured doses or in forms or packings for retail sale
Pharmaceutical products Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products; cell cultures, whether or not modified. -- Immunological products, put up in measured doses or in forms or packings for retail sale
USD 0 | 3.01%
Organic chemicals Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds. - Compounds containing an unfused thiazole ring (whether or not hydrogenated) in the structure
Organic chemicals Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds. - Compounds containing an unfused thiazole ring (whether or not hydrogenated) in the structure
USD 0 | 3.01%
Pharmaceutical products Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products; cell cultures, whether or not modified. -- Immunological products, unmixed, not put up in measured doses or in forms or packings for retail sale
Pharmaceutical products Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products; cell cultures, whether or not modified. -- Immunological products, unmixed, not put up in measured doses or in forms or packings for retail sale
USD 0 | 1.50%
Mineral fuels, mineral oils and products of their distillation; bituminous substances; mineral waxes Petroleum oils and oils obtained from bituminous minerals, other than crude; preparations not elsewhere specified or included, containing by weight 70 % or more of petroleum oils or of oils obtained from bituminous minerals, these oils being the basic constituents of the preparations; waste oils. -- Light oils and preparations
Mineral fuels, mineral oils and products of their distillation; bituminous substances; mineral waxes Petroleum oils and oils obtained from bituminous minerals, other than crude; preparations not elsewhere specified or included, containing by weight 70 % or more of petroleum oils or of oils obtained from bituminous minerals, these oils being the basic constituents of the preparations; waste oils. -- Light oils and preparations
USD 0 | 1.50%
Pharmaceutical products Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products; cell cultures, whether or not modified. - Other
Pharmaceutical products Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products; cell cultures, whether or not modified. - Other
Intel
Identify in-market buyers, prioritize high-potential accounts, and accelerate pipeline growth.
Similar Companies to we pharma ltd
Companies importing similar HS Codes as of "we pharma ltd" in united kingdom
Companies exporting similar HS Codes as of "we pharma ltd" in united kingdom
Other Buyers and Suppliers in united kingdom who deal in similar products like we pharma ltd
Explore Transformation Stories
How a US Freight Forwarder Generated
4x More Leads at $1 Cost Per Lead
Trademo’s global trade intelligence platform has allowed us to find leads easily, boosting the team’s productivity and making the process simpler.
Iliana Rodriguez
Operations Team Leader
Frequently Asked Questions
How many shipments has We Pharma Ltd in last 12 months?
In last 12 months, We Pharma Ltd has been linked to 208 verified shipments tracked through international trade data.
How can I analyze We Pharma Ltd global trade network?
With Trademo, you can explore We Pharma Ltd complete trade ecosystem including buyers, manufacturers, shipment volumes, and trade routes, helping you identify opportunities and risks.
APIs
Data License
Plans
Directories
Company
Location
United States
3000 El Camino Real, Building 4, Suite 200, Palo Alto, California 94306
India
2nd Floor, Plot No. 136, Sector 44, Gurugram, Haryana 122003
